Silencing of H19 inhibits the adipogenesis and inflammation response in ox-LDL-treated Raw264.7 cells by up-regulating miR-130b

Molecular Immunology - Tập 93 - Trang 107-114 - 2018
Yong Han1, Jie Ma1, Junping Wang2, Liping Wang1
1Department of Cardiovascular Diseases, Xi’an Honghui Hospital, Shaanxi, 710000, China
2Department of Cardiovascular Diseases, Shaanxi Friendship Hospital, Shaanxi, 710000, China

Tài liệu tham khảo

Back, 2015, Regulation of atherosclerotic plaque inflammation, J. Intern. Med., 278, 462, 10.1111/joim.12367 Bochenek, 2013, The large non-coding RNA ANRIL, which is associated with atherosclerosis, periodontitis and several forms of cancer, regulates ADIPOR1, VAMP3 and C11ORF10, Hum. Mol. Genet., 22, 4516, 10.1093/hmg/ddt299 Chistiakov, 2016, Macrophage-mediated cholesterol handling in atherosclerosis, J. Cell. Mol. Med., 20, 17, 10.1111/jcmm.12689 Congrains, 2012, CVD-associated non-coding RNA, ANRIL, modulates expression of atherogenic pathways in VSMC, Biochem. Biophys. Res. Commun., 419, 612, 10.1016/j.bbrc.2012.02.050 Dey, 2014, Long non-coding RNAs as emerging regulators of differentiation, development, and disease, Transcription, 5, e944014, 10.4161/21541272.2014.944014 Fan, 2015, Berberine alleviates ox-LDL induced inflammatory factors by up-regulation of autophagy via AMPK/mTOR signaling pathway, J. Transl. Med., 13, 92, 10.1186/s12967-015-0450-z Gao, 2015, Association of polymorphisms in long non-coding RNA H19 with coronary artery disease risk in a Chinese population, Mutat. Res., 772, 15, 10.1016/j.mrfmmm.2014.12.009 Garcia-Gonzalez, 2015, Reality of a vaccine in the prevention and treatment of atherosclerosis, Arch. Med. Res., 46, 427, 10.1016/j.arcmed.2015.06.004 Geisler, 2013, RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts, Nat. Rev. Mol. Cell Biol., 14, 699, 10.1038/nrm3679 Gong, 2011, lncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 3' UTRs via Alu elements, Nature, 470, 284, 10.1038/nature09701 Hao, 2014, The LDL-HDL profile determines the risk of atherosclerosis: a mathematical model, PLoS One, 9, e90497, 10.1371/journal.pone.0090497 Hosin, 2014, MicroRNAs in atherosclerosis, J. Vasc. Res., 51, 338, 10.1159/000368193 Hu, 2015, RP5-833A20.1/miR-382-5p/NFIA-dependent signal transduction pathway contributes to the regulation of cholesterol homeostasis and inflammatory reaction, Arterioscler. Thromb. Vasc. Biol., 35, 87, 10.1161/ATVBAHA.114.304296 Jian, 2016, Long noncoding RNAs in atherosclerosis, J. Atheroscler. Thromb., 23, 376, 10.5551/jat.33167 Jiang, 2015, The emerging roles of long noncoding RNAs in common cardiovascular diseases, Hypertens. Res., 38, 375, 10.1038/hr.2015.26 Jiang, 2014, Peripheral blood miRNAs as a biomarker for chronic cardiovascular diseases, Sci. Rep., 4, 5026, 10.1038/srep05026 Karagkiozaki, 2015, Nanomedicine for atherosclerosis: molecular imaging and treatment, J. Biomed. Nanotechnol., 11, 191, 10.1166/jbn.2015.1943 Krystal, 1990, N-myc mRNA forms an RNA-RNA duplex with endogenous antisense transcripts, Mol. Cell. Biol., 10, 4180, 10.1128/MCB.10.8.4180 Lee, 2011, miR-130 suppresses adipogenesis by inhibiting peroxisome proliferator-activated receptor gamma expression, Mol. Cell. Biol., 31, 626, 10.1128/MCB.00894-10 Loyer, 2014, Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice, Circ. Res., 114, 434, 10.1161/CIRCRESAHA.114.302213 Lv, 2015, The changes in miR-130b levels in human serum and the correlation with the severity of diabetic nephropathy, Diabetes Metab. Res. Rev., 31, 717, 10.1002/dmrr.2659 Marques-Rocha, 2015, Noncoding RNAs, cytokines, and inflammation-related diseases, FASEB J., 29, 3595, 10.1096/fj.14-260323 Mendis, 2015, Organizational update: the world health organization global status report on noncommunicable diseases 2014; one more landmark step in the combat against stroke and vascular disease, Stroke, 46, e121, 10.1161/STROKEAHA.115.008097 Mozaffarian, 2016, Heart disease and stroke statistics-2016 update: a report from the american heart association, Circulation, 133, e38, 10.1161/CIR.0000000000000350 Pan, 2017, LncRNA H19 promotes atherosclerosis by regulating MAPK and NF-kB signaling pathway, Eur. Rev. Med. Pharmacol. Sci., 21, 322 Rader, 2008, Translating molecular discoveries into new therapies for atherosclerosis, Nature, 451, 904, 10.1038/nature06796 Rapicavoli, 2013, A mammalian pseudogene lncRNA at the interface of inflammation and anti-inflammatory therapeutics, eLife, 2, e00762, 10.7554/eLife.00762 Schober, 2014, MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1, Nat. Med., 20, 368, 10.1038/nm.3487 Seneviratne, 2015, Role of inflammatory cells and toll-like receptors in atherosclerosis, Curr. Vasc. Pharmacol., 13, 146, 10.2174/15701611113116660160 Shan, 2016, Role of long non-coding RNA-RNCR3 in atherosclerosis-related vascular dysfunction, Cell. Death. Dis., 7, e2248, 10.1038/cddis.2016.145 Shao, 2016, Nur77 inhibits oxLDL induced apoptosis of macrophages via the p38 MAPK signaling pathway, Biochem. Biophys. Res. Commun., 471, 633, 10.1016/j.bbrc.2016.01.004 Tietge, 2014, Hyperlipidemia and cardiovascular disease: inflammation, dyslipidemia, and atherosclerosis, Curr. Opin. Lipidol., 25, 94, 10.1097/MOL.0000000000000051 Tuttolomondo, 2012, Atherosclerosis as an inflammatory disease, Curr. Pharm. Des., 18, 4266, 10.2174/138161212802481237 Uchida, 2015, Long noncoding RNAs in cardiovascular diseases, Circ. Res., 116, 737, 10.1161/CIRCRESAHA.116.302521 van Diepen, 2013, Interactions between inflammation and lipid metabolism: relevance for efficacy of anti-inflammatory drugs in the treatment of atherosclerosis, Atherosclerosis, 228, 306, 10.1016/j.atherosclerosis.2013.02.028 Viola, 2015, Atherosclerosis – a matter of unresolved inflammation, Semin. Immunol., 27, 184, 10.1016/j.smim.2015.03.013 Weber, 2011, Atherosclerosis: current pathogenesis and therapeutic options, Nat. Med., 17, 1410, 10.1038/nm.2538 Xie, 2014, [Ac-hE-18A-NH2 inhibits the inflammatory response induced by ox-LDL via inhibiting NF-kappaB activation in RAW264.7 macrophages], Zhong nan da xue xue bao. Yi xue ban=J. Cent. South Univ. Med. Sci., 39, 232 Yin, 2016, EGCG attenuates atherosclerosis through the Jagged-1/Notch pathway, Int. J. Mol. Med., 37, 398, 10.3892/ijmm.2015.2422 Yoon, 2012, LincRNA-p21 suppresses target mRNA translation, Mol. Cell, 47, 648, 10.1016/j.molcel.2012.06.027 Yuan, 2014, A long noncoding RNA activated by TGF-beta promotes the invasion-metastasis cascade in hepatocellular carcinoma, Cancer Cell, 25, 666, 10.1016/j.ccr.2014.03.010 Zhang, 2015, Nifedipine inhibits ox-LDL-induced lipid accumulation in human blood-derived macrophages, Biochem. Biophys. Res. Commun., 457, 440, 10.1016/j.bbrc.2015.01.010 Zhao, 2013, Activation of TRPV1 prevents OxLDL-induced lipid accumulation and TNF-alpha-induced inflammation in macrophages: role of liver X receptor alpha, Mediators Inflamm., 2013, 925171, 10.1155/2013/925171 Zheng, 2016, Regulation and mechanism of mouse miR-130a/b in metabolism-related inflammation, Int. J. Biochem. Cell Biol., 74, 72, 10.1016/j.biocel.2016.02.021